Day: August 2, 2022

Differentiated operational flexibility and demand-driven rate strength combine to deliver year-over-year improvements in the quarter; company raises full year revenue guidance ADDISON, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the premier North American transportation solutions specialist dedicated to servicing challenging industrial end-markets, today reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights:Revenue of $481.3 million, up 19.1% year-over-year Net Income of $17.7 million, or $0.24 per diluted share attributable to common stockholders, compared to net income of $35.3 million, or $0.49, in the second quarter of 2021 Adjusted Net Income of $30.0 million, or $0.42 per diluted share attributable to common stockholders,...

Results for the Second Quarter of 2022Net income of $10.5 million, or $0.44 per common unit Adjusted EBITDA of $12.9 million and distributable cash flow of $11.3 million Quarterly cash distribution increased to $0.45 per unit Distribution coverage ratio of 1.06x; LTM distribution coverage ratio of 1.07x Leverage ratio, net of cash; 0.82x Adjusted EBITDAOMAHA, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the second quarter of 2022. Net income attributable to the partnership was $10.5 million, or $0.44 per common unit, for the second quarter of 2022, compared with net income of $10.3 million, or $0.44 per common unit, for the same period in 2021. The partnership also reported adjusted EBITDA of $12.9 million and distributable cash flow of $11.3...

Results for the Second Quarter of 2022:Second quarter net income attributable to Green Plains of $46.4 million and EPS of $0.73 per diluted share, compared to net income attributable to Green Plains of $9.7 million and EPS of $0.20 per diluted share for the same period in the prior year EBITDA of $84.4 million, inclusive of a USDA COVID relief payment of $27.7 million, compared to $50.9 million for the same period in the prior year Consolidated crush margin of $0.28 per gallon for the second quarter Plant utilization rate of 96.9%, demonstrating the ability of our upgraded production platform $604.2 million of cash, cash equivalents, restricted cash and marketable securities; $70.0 million available under a committed credit facility Commissioning of the MSC™ system in Central City, Nebraska, began in July and anticipate commissioning...

WAKIX®(pitolisant) Net Revenue of $107.0 Million for Second Quarter 2022 Increase of 45% vs. the Same Period in 2021 Average Number of Patients on WAKIX Increased to ~4,300 Signs New Agreement with Bioprojet Focused on Developing Innovative Therapeutics Based on Pitolisant, Expanding Harmony’s Opportunity in Narcolepsy Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study on Track with Site Activations and Patient Enrollment Conference Call and Webcast to be Held Today at 8:30 a.m. ET PLYMOUTH MEETING, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company focused on delivering innovative therapies that improve the health of people living with rare neurological diseases, today reported financial results and business updates for the quarter ended...

Record revenue of $207.6 million for the quarter, representing overall growth of 27% as reported and 32% at constant currency (year-over-year) Strong organic revenue growth of 29% and strong base business growth of 41% for the quarter Revenue guidance raised to $790 – $810 million for full year 2022WALTHAM, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its second quarter ended June 30, 2022. Provided in this press release are financial highlights for the three- and six-month periods ended June 30, 2022, updates to our financial guidance for the year 2022 and access information for today’s webcast and conference call. Tony J. Hunt, President and Chief Executive Officer said, “I’m very...

Revenue increased 13.3% from the prior year period to $615.4 millionDays adjusted same-facility revenues increased 6.9% from the prior year periodNet loss attributable to common stockholders was $18.4 millionAdjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefit from the recognition of CARES Act grants Excluding CARES Act grants, Adjusted EBITDA increased 17.8% over the prior year period, with Adjusted EBITDA margins of 14.0%Reaffirm projected 2022 Adjusted EBITDA in the range of $375 million to $385 million and 2022 revenue in the range of $2.5 billion to $2.6 billionBRENTWOOD, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services,...

Second Quarter 2022 Highlights (all comparisons are made to the prior year second quarter):Net Sales increased 14.6% to $318.2 million Gross Profit Margin of 19.0% decreased 480 bps Net Income decreased 147.0% to a loss of $3.9 million; Adjusted Net Income of $4.3 million decreased 59.0% from $10.5 million Diluted EPS of $(0.17) compared to $0.36; Adjusted EPS of $0.19 decreased from $0.46 Backlog increased 92.0% to a record level of $837.4 millionCHATTANOOGA, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) — Astec Industries, Inc. (Nasdaq: ASTE) announced today its financial results for the second quarter of 2022. Second quarter of 2022 net sales of $318.2 million increased 14.6% compared to $277.6 million for the second quarter of 2021, an increase of $40.6 million or 14.6%. The increase in net sales was driven by volume, pricing and...

Revenues Q2 of $864 million. Gross margin Q2 of 30.3%; adjusted gross margin of 31.0% Operating margin Q2 of 17.5%; adjusted operating margin of 18.3%. EPS Q2 of $0.78; adjusted EPS of $0.82. Free Cash for the trailing 12 months of $139 million. Total Stockholder Return Q2 of $40.6 million–$14.3 million of dividend payments and $26.3 million of stock repurchases. Guidance Q3 2022 for revenues of $860 to $900 million and at a gross margin of 29.0% plus/minus 50 basis points at an exchange rate USD/EUR of 0.98.MALVERN, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, today announced its results for the fiscal quarter and six fiscal months ended July 2, 2022. Revenues for the fiscal quarter ended...

 Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) today announces its consolidated preliminary results for the second quarter and six months ended June 30, 2022. Results for the Q2 are summarized as follows:Total shipments of 3,455 units, up 28.7% versus Q2 2021 Net revenues of Euro 1,291 million, up 24.9% versus prior year EBITDA of Euro 446 million, up 15.5% versus prior year EBIT of Euro 323 million, up 17.8% versus prior year EBITDA margin of 34.6% and EBIT margin of 25.0%, in line with full year targets Net profit of Euro 251 million and diluted EPS at Euro 1.36 Industrial free cash flow generation of Euro 79 million, implying the best ever Q2 in terms of operating performance before taxes“Ferrari continues a phase of strong growth, with quarterly record results in terms of revenues, EBITDA and EBIT. The quality of...